Status:
RECRUITING
German MPN-Registry for BCR-ABL 1-Negative Myeloid Neoplasms (Study Group Ulm)
Lead Sponsor:
University of Ulm
Conditions:
BCR-ABL1-Negative Myeloid Neoplasms
Eligibility:
All Genders
18+ years
Brief Summary
To register a large number of patients with the diagnosis of a BCR-ABL 1- negative myeloid neoplasm (according to WHO 2008 / 2016 classification) in participating centers To store samples from all pa...
Detailed Description
To register a large number of patients with the diagnosis of a BCR-ABL 1- negative myeloid neoplasm (according to WHO 2008 / 2016 classification) in participating centers To store samples from all pa...
Eligibility Criteria
Inclusion
- Both female and male patients meeting the mentioned inclusion criteria will be included in this registry, because the risk to get a myeloid neoplasm does not depend on a patient's gender. Patients must meet all of the following inclusion criteria to be eligible for enrollment into the registry:
- Patients with BCR-ABL 1-myeloid neoplasia according to WHO classification or IWG MRI criteria
- Age ≥ 18 years. There is no upper age limit.
- Signed written informed consent.
Exclusion
- Severe neurological or psychiatric disorder interfering with ability to give an informed consent
- No consent for registration, storage and handling of the personal data
Key Trial Info
Start Date :
May 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2045
Estimated Enrollment :
2172 Patients enrolled
Trial Details
Trial ID
NCT03125707
Start Date
May 1 2013
End Date
September 1 2045
Last Update
May 19 2023
Active Locations (30)
Enter a location and click search to find clinical trials sorted by distance.
1
Hämatologische Onkologie Praxis Augsburg
Augsburg, Germany, 86150
2
Klinikum Augsburg
Augsburg, Germany, 86156
3
Helios Klinikum, Bad Saarow
Bad Saarow, Germany, 15526
4
Klinikum Mittelbaden
Baden-Baden, Germany, 76532